ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 20.5606 ↓ -0.35%
[as on 13 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 13 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 20.87% -0.35% 2.4% 8.28% 3.4% 16.8% 20.53% 15.45%--
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.29% -0.27% 0.2% 3.18% -6.26% -10.5% 4.93% 8.92% 13.82% 14.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth 0.75% -0.5% 1.2% 9.63% 2.07% 1.58% 11.19% 7.88% 12.9% 12.67%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 29.68% -0.01% 3.26% 10.03% 4.42% 26.07% 25.42% 20.65% 26.17% 15.92%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.39% -0.04% 1.28% 6.76% -0.65% 3.49% 12.47% 14.96% 19.21% 15.81%
SBI COMMA Fund - DIRECT PLAN - Growth 4.37% -0.55% 0.42% 4.29% -2.46% 6.57% 14.27% 9.88% 18.09% 14.96%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -6.9% 35.22% 44.46% -9.08%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -6.81% 6.98% -4.59% 7.71% 3.1% 5.95% 4.02% 2.89% -2.83% 0.38%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 6.59%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.27% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.73%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.58%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.23%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.72%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.84%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.75%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.31%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.22%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.02%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.97%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.31%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.18%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.10%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.98%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.92%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.82%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.43%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology1.97%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.92%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.59%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.59%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.55%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.50%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services1.47%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.32%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Consumer Durables1.25%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.25%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.15%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology1.02%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.99%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services0.93%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.87%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.81%
Metropolis Healthcare LimitedMETROPOLIS (INE112L01020)Healthcare Services0.74%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.71%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.61%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.60%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
13 November, 202620.5606 -0.35%
12 November, 202620.6326 -0.05%
11 November, 202620.6432 -0.03%
9 November, 202620.6503 2.85%
6 November, 202620.0784 0.51%
5 November, 202619.9767 0.52%
4 November, 202619.8730 1.3%
3 November, 202619.6170 0.6%
2 November, 202619.4995 0.18%
30 October, 202619.4636 0.91%
29 October, 202619.2887 0.36%
28 October, 202619.2196 1.23%
27 October, 202618.9865 2%
26 October, 202618.6137 1.71%
23 October, 202618.3005 -0.94%
22 October, 202618.4740 -0.09%
21 October, 202618.4898 -0.54%
19 October, 202618.5899 -1.03%
16 October, 202618.7836 -0.23%
15 October, 202618.8270 0.16%
14 October, 202618.7968 -1.01%
13 October, 202618.9885 -0.29%
12 October, 202619.0442 0%
9 October, 202619.0438 0.65%
8 October, 202618.9208 -2.36%
7 October, 202619.3776 -0.35%
6 October, 202619.4465 1.11%
5 October, 202619.2322 -1%
1 October, 202619.4256 -0.19%
30 September, 202619.4628

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 20.5606 as on 13 November, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 20.87% as on 13 November, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 16.8% as on 13 November, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 20.53% as on 13 November, 2026.
  • What are 5 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 5 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 15.45% as on 13 November, 2026.
  • What are top 10 holdings of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    Top 10 holdings of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are:
    • Sun Pharmaceutical Industries Limited
    • Divi's Laboratories Limited
    • Apollo Hospitals Enterprise Limited
    • Max Healthcare Institute Limited
    • Torrent Pharmaceuticals Limited
    • Dr. Reddy's Laboratories Limited
    • Cipla Limited
    • Laurus Labs Limited
    • Aurobindo Pharma Limited
    • Mankind Pharma Limited
    • Neuland Laboratories Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.